The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2023

Filed:

Feb. 19, 2020
Applicants:

Biontech Ag, Mainz, DE;

Ganymed Pharmaceuticals Gmbh, Mainz, DE;

Tron—translationale Onkologie an Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz, Mainz, DE;

Inventors:

Ugur Sahin, Mainz, DE;

Ozlem Tureci, Mainz, DE;

Korden Walter, Mainz, DE;

Meike Wagner, Mainz, DE;

Maria Kreuzberg, Mainz, DE;

Sabine Hacker, Mainz, DE;

Stefan Jacobs, Mainz-Kastel, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 31/337 (2006.01); A61K 31/5365 (2006.01); A61K 31/7048 (2006.01); A61K 31/7064 (2006.01); A61K 33/243 (2019.01); C07K 16/30 (2006.01); A61K 47/68 (2017.01); G01N 33/574 (2006.01); A61N 5/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 31/337 (2013.01); A61K 31/5365 (2013.01); A61K 31/7048 (2013.01); A61K 31/7064 (2013.01); A61K 33/243 (2019.01); A61K 39/39558 (2013.01); A61K 47/6851 (2017.08); A61N 5/10 (2013.01); C07K 16/30 (2013.01); G01N 33/57484 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); C07K 2317/56 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); G01N 2333/705 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention provides methods for diagnosis or treatment of cancer diseases involving cancer stem cells comprising targeting CLDN6. In particular, the present invention provides a method of determining cancer stem cells comprising detecting cells expressing CLDN6. Furthermore, the present invention provides a method of treating or preventing cancer comprising inhibiting and/or eliminating cancer stem cells by administering an antibody having the ability of binding to CLDN6 to a cancer patient.


Find Patent Forward Citations

Loading…